Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€9.10

€9.10

-0.660%
-
-0.660%
-

-

 
08.05.24 / Tradegate WKN: A3E5A5 / Name: SynBiotic / Stock / Small Cap /
Latest predictions
€20.00
25.03.24
-30.00%
Best running prediction
€20.00
25.03.24
-30.00%
Your prediction

SynBiotic SE Stock

SynBiotic SE shows a slight decrease today, losing €0.000 (-0.660%) compared to yesterday.
Our community identified positive and negative aspects for SynBiotic SE stock for the coming years. 0 users see the criterium "Market Position" as a plus for the SynBiotic SE stock. On the other hand our users think that "Market Position" could be a problem in the future.

Pros and Cons of SynBiotic SE in the next few years

Pros
?
G***** c******* t* c**********
?
M***** P*******
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

News

EQS-News: Acquisition of WEECO Pharma: SYNBIOTIC significantly expands its position in the medical cannabis market
EQS-News: Acquisition of WEECO Pharma: SYNBIOTIC significantly expands its position in the medical cannabis market
EQS-News: Acquisition of WEECO Pharma: SYNBIOTIC significantly expands its position in the medical cannabis market
EQS-News: 1.6 million euros for Hanf Farm: Federal Ministry for Economic Affairs and Climate Protection funds bio-economy project
EQS-News: 1.6 million euros for Hanf Farm: Federal Ministry for Economic Affairs and Climate Protection funds bio-economy project
EQS-News: 1.6 million euros for Hanf Farm: Federal Ministry for Economic Affairs and Climate Protection funds bio-economy project
EQS-News: SYNBIOTIC acquires Ilesol: Enormous competitive advantages through cannabinoid extracts and isolates from own production
EQS-News: SYNBIOTIC acquires Ilesol: Enormous competitive advantages through cannabinoid extracts and isolates from own production
EQS-News: SYNBIOTIC acquires Ilesol: Enormous competitive advantages through cannabinoid extracts and isolates from own production